Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence L Rudel

Showing results (31-40 of 93) with videos related to

Pageof 10
Sort By:
The Journal of Antibiotics|January 23, 2009
Selective inhibition of acyl-CoA:cholesterol acyltransferase 2 isozyme by flavasperone and sterigmatocystin from Aspergillus speciesKent Sakai, Satoshi Ohte, Taichi Ohshiro, et al.
Journal of Lipid Research|November 18, 2003
Identification of ACAT1- and ACAT2-specific inhibitors using a novel, cell-based fluorescence assay: individual ACAT uniquenessAaron T Lada, Matthew Davis, Carol Kent, et al.
The Journal of Clinical Investigation|September 22, 2007
Macrophage-specific transgenic expression of cholesteryl ester hydrolase significantly reduces atherosclerosis and lesion necrosis in Ldlr miceBin Zhao, Jingmei Song, Woon N Chow, et al.
Lipids|January 6, 2016
Sterol O-Acyltransferase 2-Driven Cholesterol Esterification Opposes Liver X Receptor-Stimulated Fecal Neutral Sterol LossManya Warrier, Jun Zhang, Kanwardeep Bura, et al.
Journal of Lipid Research|April 5, 2005
ACAT2 contributes cholesteryl esters to newly secreted VLDL, whereas LCAT adds cholesteryl ester to LDL in miceRichard G Lee, Ramesh Shah, Janet K Sawyer, et al.
Scientific Reports|June 25, 2017
Selective inhibition of sterolO-acyltransferase 1 isozyme by beauveriolide III in intact cellsTaichi Ohshiro, Keisuke Kobayashi, Mio Ohba, et al.
Bioorganic & Medicinal Chemistry Letters|March 29, 2013
Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 2Masaki Ohtawa, Hiroyuki Yamazaki, Daisuke Matsuda, et al.
Journal of Lipid Research|September 3, 2003
Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expressionFayanne E Thorngate, Patricia G Yancey, Ginny Kellner-Weibel, et al.
Circulation Research|October 16, 2004
Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potentialRichard G Lee, Kathryn L Kelley, Janet K Sawyer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 6, 2006
Liver-specific inhibition of acyl-coenzyme a:cholesterol acyltransferase 2 with antisense oligonucleotides limits atherosclerosis development in apolipoprotein B100-only low-density lipoprotein receptor-/- miceThomas A Bell, J Mark Brown, Mark J Graham, et al.
Pageof 10

Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
The Journal of Antibiotics|January 23, 2009
Selective inhibition of acyl-CoA:cholesterol acyltransferase 2 isozyme by flavasperone and sterigmatocystin from Aspergillus speciesKent Sakai, Satoshi Ohte, Taichi Ohshiro, et al.
Journal of Lipid Research|November 18, 2003
Identification of ACAT1- and ACAT2-specific inhibitors using a novel, cell-based fluorescence assay: individual ACAT uniquenessAaron T Lada, Matthew Davis, Carol Kent, et al.
The Journal of Clinical Investigation|September 22, 2007
Macrophage-specific transgenic expression of cholesteryl ester hydrolase significantly reduces atherosclerosis and lesion necrosis in Ldlr miceBin Zhao, Jingmei Song, Woon N Chow, et al.
Lipids|January 6, 2016
Sterol O-Acyltransferase 2-Driven Cholesterol Esterification Opposes Liver X Receptor-Stimulated Fecal Neutral Sterol LossManya Warrier, Jun Zhang, Kanwardeep Bura, et al.
Journal of Lipid Research|April 5, 2005
ACAT2 contributes cholesteryl esters to newly secreted VLDL, whereas LCAT adds cholesteryl ester to LDL in miceRichard G Lee, Ramesh Shah, Janet K Sawyer, et al.
Scientific Reports|June 25, 2017
Selective inhibition of sterolO-acyltransferase 1 isozyme by beauveriolide III in intact cellsTaichi Ohshiro, Keisuke Kobayashi, Mio Ohba, et al.
Bioorganic & Medicinal Chemistry Letters|March 29, 2013
Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 2Masaki Ohtawa, Hiroyuki Yamazaki, Daisuke Matsuda, et al.
Journal of Lipid Research|September 3, 2003
Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expressionFayanne E Thorngate, Patricia G Yancey, Ginny Kellner-Weibel, et al.
Circulation Research|October 16, 2004
Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potentialRichard G Lee, Kathryn L Kelley, Janet K Sawyer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 6, 2006
Liver-specific inhibition of acyl-coenzyme a:cholesterol acyltransferase 2 with antisense oligonucleotides limits atherosclerosis development in apolipoprotein B100-only low-density lipoprotein receptor-/- miceThomas A Bell, J Mark Brown, Mark J Graham, et al.
Pageof 10